- Congress Shouldn’t Pass the 21st Century Cures Act in a Summer Rush, Health Affairs Blog – with published comments from NPA FDA Task Force members Lisa Plymate, MD, and Elizabeth Wiley, MD, JD, MPH (7/11/2016)
- Patient advocates urge action on clinical trials reporting, Stat News (4/14/2016)
- More than 50 health, religious and labor groups urge Congress to reject TPP trade deal, Washington Post (4/12/2016)
- Top 5 reasons why Doctors Without Borders and more than 50 other organisations don’t like the TPP, Medium (4/12/2016)
- NPA FDA Task Force Member, Dr. Andrew Kolodny, Joins Senators Markey & Manchin Press Conference: Reform FDA to Address Opioid Crisis (2/22/2016)
- Critics see accountability risk if FDA rule changes take hold, Star Tribune (2/14/2016)
- “Thousands of lives lost”? Why calls for faster drug approvals need more scrutiny, Health News Review (1/7/2016)
- “Defining antibiotic effectiveness and resistance: how a private party may soon rule judgments over susceptibility testing?” BMJ (1/6/2016)
- “Critics continue pounding 21st Century Cures Act for threatening patient safety,” Medical Economics (12/30/2015)
- “The last word: Will 21st Century Cures Act harm patient safety?” Medical Economics (12/25/2015)
- “Deregulating the FDA: Back to thalidomide?” The Hill (12/2/2015)
- “Dr. Andrew Kolodny on Combating Drug Abuse,” C-Span (10/25/2015)
- “How fast to “cures” and at what cost? Politico forum tilts toward pharma-friendly messaging,” HealthNewsReview (10/22/2015)
- “Would Washington’s FDA Fix Cure the Patients or the Drug Industry?,” ProPublica (10/20/2015)
- “’21st Century Cures’ Isn’t a Cure for Everything,” Managed Care (9/2015)
- “FDA Panel Recommends Two New Antibiotics – Speakers Debate Agency’s Approach to Drugs for Resistant Infections,” Wall Street Journal (3/31/2014)
- “Health groups fight Republican push to deregulate medical technology,” The Hill, (2/21/2014)
Barbara Meier schreibt seit vielen Jahren für die NPAlliance Ratgeber und Testberichte. Dabei legt sie großen Wert auf die Ausführlichkeit sowie Richtigkeit ihrer Artikel. Sie zählt zu den wenigen Experten in ihrem Gebiet und hat sich über die letzten Jahren einen Namen in der Gesundheitsbranche gemacht.